Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7974)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 21, 2016 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Balakrishnan A, Vyas A, Deshpande K, Vyas D. Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer. World J Gastroenterol 2016; 22(7): 2159-2164 [PMID: 26900281 DOI: 10.3748/wjg.v22.i7.2159] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i7/2159.htm |
| Number | Citing Articles |
| 1 |
Srijayaprakash Babu Uppada, Saiprasad Gowrikumar, Rizwan Ahmad, Balawant Kumar, Bryan Szeglin, Xi Chen, J. Joshua Smith, Surinder K. Batra, Amar B. Singh, Punita Dhawan. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0848-3
|
| 2 |
Sonal M. Manohar, Kalpana S. Joshi. Promising Anticancer Activity of Multitarget Cyclin Dependent Kinase
Inhibitors against Human Colorectal Carcinoma Cells. Current Molecular Pharmacology 2022; 15(7): 1024 doi: 10.2174/1874467215666220124125809
|
| 3 |
Fatima Arshad, Mohemmed Faraz Khan, Wasim Akhtar, Mohammad Mumtaz Alam, Lalit Mohan Nainwal, Sumit Kumar Kaushik, Mymoona Akhter, Suhel Parvez, Syed Misbahul Hasan, Mohammad Shaquiquzzaman. Revealing quinquennial anticancer journey of morpholine: A SAR based review. European Journal of Medicinal Chemistry 2019; 167: 324 doi: 10.1016/j.ejmech.2019.02.015
|
| 4 |
Ogochukwu O. Izuegbuna. Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1008893
|
| 5 |
Ziyan Yang, Guiyuan Chen. Inhibition of Proliferation and Induction of Apoptosis in Prostatic Carcinoma DU145 Cells by Polysaccharides from Yunnan Rosa roxburghii Tratt. Molecules 2024; 29(7): 1575 doi: 10.3390/molecules29071575
|
| 6 |
Shaimaa A. Morsy, Abdelbasset A. Farahat, Magda N.A. Nasr, Atif S. Tantawy. Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds. Saudi Pharmaceutical Journal 2017; 25(6): 873 doi: 10.1016/j.jsps.2017.02.003
|
| 7 |
Clement Opoku-Temeng, Neetu Dayal, Delmis E. Hernandez, N. Naganna, Herman O. Sintim. Tetrahydro-3H-pyrazolo[4,3-a]phenanthridine-based CDK inhibitor. Chemical Communications 2018; 54(36): 4521 doi: 10.1039/C8CC01154K
|
| 8 |
Narjes Hendouei, Fatemeh Saghafi, Faezeh Shadfar, Seyed Jalal Hosseinimehr. Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment. European Journal of Pharmacology 2019; 856: 172402 doi: 10.1016/j.ejphar.2019.05.031
|
| 9 |
Mamie Gao, Allen Zhong, Neil Patel, Chiraag Alur, Dinesh Vyas. High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases. World Journal of Gastroenterology 2017; 23(16): 2819-2825 doi: 10.3748/wjg.v23.i16.2819
|
| 10 |
Caroline M. Robb, Smit Kour, Jacob I. Contreras, Ekta Agarwal, Carter J. Barger, Sandeep Rana, Yogesh Sonawane, Beth K. Neilsen, Margaret Taylor, Smitha Kizhake, Rhishikesh N. Thakare, Sanjib Chowdhury, Jing Wang, Jennifer D. Black, Michael A. Hollingsworth, Michael G. Brattain, Amarnath Natarajan. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget 2018; 9(4): 5216 doi: 10.18632/oncotarget.23749
|
| 11 |
Xianhua Gu, Honghong Shen, Wenqi Bai, Zheng Xiang, Xinwei Li, Rong Zhang, Fan Shi, Huiyuan Li, Guangzheng Zhu, Suyang Guo. Endometrial cancer prognosis prediction using correlation models based on CDK family genes. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.1021600
|
| 12 |
Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Olalekan Olanrewaju Bakare, Ashwil Klein, Abram Madimabe Madiehe, Mervin Meyer. Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer. Biotechnology Reports 2021; 29: e00602 doi: 10.1016/j.btre.2021.e00602
|
| 13 |
Quanbo Ji, Xiaojie Xu, Ling Li, Stuart B Goodman, Wenzhi Bi, Meng Xu, Yameng Xu, Zhongyi Fan, William J Maloney, Qinong Ye, Yan Wang. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14. Cell Death & Disease 2017; 8(10): e3103 doi: 10.1038/cddis.2017.499
|
| 14 |
Yuewen Qi, Haowen Qi, Zeyuan Liu, Peiyuan He, Bingqing Li. Bioinformatics Analysis of Key Genes and Pathways in Colorectal Cancer. Journal of Computational Biology 2019; 26(4): 364 doi: 10.1089/cmb.2018.0237
|